The global Immune Cell Therapy Drugs market size was valued at US$ 3308 million in 2024 and is forecast to a readjusted size of USD 21970 million by 2031 with a CAGR of 31.4% during review period.
Immune Cell Therapy Drugs refer to medications that are used in immune cell therapies to modulate and enhance the patient"s immune response against diseases like cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Immune Cell Therapy Drugs market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Immune Cell Therapy Drugs market size and forecasts, in consumption value ($ Million), 2020-2031
Global Immune Cell Therapy Drugs market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Immune Cell Therapy Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Immune Cell Therapy Drugs market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Immune Cell Therapy Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Immune Cell Therapy Drugs market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aquila BioMedical, BPS Bioscience, Celentyx, Crown Bioscience, DiscoverX Corporation, Explicyte, Genscript Biotech Corporation, HD Biosciences, Horizon Discovery Group, ImmunXperts, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Immune Cell Therapy Drugs market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monoclonal Antibodies
Immunomodulator
Other
Market segment by Application
Stomach Cancer
lung Cancer
Colorectal Cancer
Esophageal Cancer
Pancreatic Cancer
Other
Market segment by players, this report covers
Aquila BioMedical
BPS Bioscience
Celentyx
Crown Bioscience
DiscoverX Corporation
Explicyte
Genscript Biotech Corporation
HD Biosciences
Horizon Discovery Group
ImmunXperts
Molecular Imaging
Promega Corporation,Personalis
STC Biologics
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Immune Cell Therapy Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Immune Cell Therapy Drugs, with revenue, gross margin, and global market share of Immune Cell Therapy Drugs from 2020 to 2025.
Chapter 3, the Immune Cell Therapy Drugs competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Immune Cell Therapy Drugs market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Immune Cell Therapy Drugs.
Chapter 13, to describe Immune Cell Therapy Drugs research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Immune Cell Therapy Drugs by Type
1.3.1 Overview: Global Immune Cell Therapy Drugs Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Immune Cell Therapy Drugs Consumption Value Market Share by Type in 2024
1.3.3 Monoclonal Antibodies
1.3.4 Immunomodulator
1.3.5 Other
1.4 Global Immune Cell Therapy Drugs Market by Application
1.4.1 Overview: Global Immune Cell Therapy Drugs Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Stomach Cancer
1.4.3 lung Cancer
1.4.4 Colorectal Cancer
1.4.5 Esophageal Cancer
1.4.6 Pancreatic Cancer
1.4.7 Other
1.5 Global Immune Cell Therapy Drugs Market Size & Forecast
1.6 Global Immune Cell Therapy Drugs Market Size and Forecast by Region
1.6.1 Global Immune Cell Therapy Drugs Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Immune Cell Therapy Drugs Market Size by Region, (2020-2031)
1.6.3 North America Immune Cell Therapy Drugs Market Size and Prospect (2020-2031)
1.6.4 Europe Immune Cell Therapy Drugs Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Immune Cell Therapy Drugs Market Size and Prospect (2020-2031)
1.6.6 South America Immune Cell Therapy Drugs Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Immune Cell Therapy Drugs Market Size and Prospect (2020-2031)
2 Company Profiles
2.1 Aquila BioMedical
2.1.1 Aquila BioMedical Details
2.1.2 Aquila BioMedical Major Business
2.1.3 Aquila BioMedical Immune Cell Therapy Drugs Product and Solutions
2.1.4 Aquila BioMedical Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Aquila BioMedical Recent Developments and Future Plans
2.2 BPS Bioscience
2.2.1 BPS Bioscience Details
2.2.2 BPS Bioscience Major Business
2.2.3 BPS Bioscience Immune Cell Therapy Drugs Product and Solutions
2.2.4 BPS Bioscience Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 BPS Bioscience Recent Developments and Future Plans
2.3 Celentyx
2.3.1 Celentyx Details
2.3.2 Celentyx Major Business
2.3.3 Celentyx Immune Cell Therapy Drugs Product and Solutions
2.3.4 Celentyx Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Celentyx Recent Developments and Future Plans
2.4 Crown Bioscience
2.4.1 Crown Bioscience Details
2.4.2 Crown Bioscience Major Business
2.4.3 Crown Bioscience Immune Cell Therapy Drugs Product and Solutions
2.4.4 Crown Bioscience Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Crown Bioscience Recent Developments and Future Plans
2.5 DiscoverX Corporation
2.5.1 DiscoverX Corporation Details
2.5.2 DiscoverX Corporation Major Business
2.5.3 DiscoverX Corporation Immune Cell Therapy Drugs Product and Solutions
2.5.4 DiscoverX Corporation Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 DiscoverX Corporation Recent Developments and Future Plans
2.6 Explicyte
2.6.1 Explicyte Details
2.6.2 Explicyte Major Business
2.6.3 Explicyte Immune Cell Therapy Drugs Product and Solutions
2.6.4 Explicyte Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Explicyte Recent Developments and Future Plans
2.7 Genscript Biotech Corporation
2.7.1 Genscript Biotech Corporation Details
2.7.2 Genscript Biotech Corporation Major Business
2.7.3 Genscript Biotech Corporation Immune Cell Therapy Drugs Product and Solutions
2.7.4 Genscript Biotech Corporation Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Genscript Biotech Corporation Recent Developments and Future Plans
2.8 HD Biosciences
2.8.1 HD Biosciences Details
2.8.2 HD Biosciences Major Business
2.8.3 HD Biosciences Immune Cell Therapy Drugs Product and Solutions
2.8.4 HD Biosciences Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 HD Biosciences Recent Developments and Future Plans
2.9 Horizon Discovery Group
2.9.1 Horizon Discovery Group Details
2.9.2 Horizon Discovery Group Major Business
2.9.3 Horizon Discovery Group Immune Cell Therapy Drugs Product and Solutions
2.9.4 Horizon Discovery Group Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Horizon Discovery Group Recent Developments and Future Plans
2.10 ImmunXperts
2.10.1 ImmunXperts Details
2.10.2 ImmunXperts Major Business
2.10.3 ImmunXperts Immune Cell Therapy Drugs Product and Solutions
2.10.4 ImmunXperts Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 ImmunXperts Recent Developments and Future Plans
2.11 Molecular Imaging
2.11.1 Molecular Imaging Details
2.11.2 Molecular Imaging Major Business
2.11.3 Molecular Imaging Immune Cell Therapy Drugs Product and Solutions
2.11.4 Molecular Imaging Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Molecular Imaging Recent Developments and Future Plans
2.12 Promega Corporation,Personalis
2.12.1 Promega Corporation,Personalis Details
2.12.2 Promega Corporation,Personalis Major Business
2.12.3 Promega Corporation,Personalis Immune Cell Therapy Drugs Product and Solutions
2.12.4 Promega Corporation,Personalis Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Promega Corporation,Personalis Recent Developments and Future Plans
2.13 STC Biologics
2.13.1 STC Biologics Details
2.13.2 STC Biologics Major Business
2.13.3 STC Biologics Immune Cell Therapy Drugs Product and Solutions
2.13.4 STC Biologics Immune Cell Therapy Drugs Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 STC Biologics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Immune Cell Therapy Drugs Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Immune Cell Therapy Drugs by Company Revenue
3.2.2 Top 3 Immune Cell Therapy Drugs Players Market Share in 2024
3.2.3 Top 6 Immune Cell Therapy Drugs Players Market Share in 2024
3.3 Immune Cell Therapy Drugs Market: Overall Company Footprint Analysis
3.3.1 Immune Cell Therapy Drugs Market: Region Footprint
3.3.2 Immune Cell Therapy Drugs Market: Company Product Type Footprint
3.3.3 Immune Cell Therapy Drugs Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Immune Cell Therapy Drugs Consumption Value and Market Share by Type (2020-2025)
4.2 Global Immune Cell Therapy Drugs Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
5.1 Global Immune Cell Therapy Drugs Consumption Value Market Share by Application (2020-2025)
5.2 Global Immune Cell Therapy Drugs Market Forecast by Application (2026-2031)
6 North America
6.1 North America Immune Cell Therapy Drugs Consumption Value by Type (2020-2031)
6.2 North America Immune Cell Therapy Drugs Market Size by Application (2020-2031)
6.3 North America Immune Cell Therapy Drugs Market Size by Country
6.3.1 North America Immune Cell Therapy Drugs Consumption Value by Country (2020-2031)
6.3.2 United States Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
6.3.3 Canada Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
6.3.4 Mexico Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
7 Europe
7.1 Europe Immune Cell Therapy Drugs Consumption Value by Type (2020-2031)
7.2 Europe Immune Cell Therapy Drugs Consumption Value by Application (2020-2031)
7.3 Europe Immune Cell Therapy Drugs Market Size by Country
7.3.1 Europe Immune Cell Therapy Drugs Consumption Value by Country (2020-2031)
7.3.2 Germany Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
7.3.3 France Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
7.3.5 Russia Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
7.3.6 Italy Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Immune Cell Therapy Drugs Market Size by Region
8.3.1 Asia-Pacific Immune Cell Therapy Drugs Consumption Value by Region (2020-2031)
8.3.2 China Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
8.3.3 Japan Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
8.3.4 South Korea Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
8.3.5 India Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
8.3.7 Australia Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
9 South America
9.1 South America Immune Cell Therapy Drugs Consumption Value by Type (2020-2031)
9.2 South America Immune Cell Therapy Drugs Consumption Value by Application (2020-2031)
9.3 South America Immune Cell Therapy Drugs Market Size by Country
9.3.1 South America Immune Cell Therapy Drugs Consumption Value by Country (2020-2031)
9.3.2 Brazil Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
9.3.3 Argentina Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Immune Cell Therapy Drugs Market Size by Country
10.3.1 Middle East & Africa Immune Cell Therapy Drugs Consumption Value by Country (2020-2031)
10.3.2 Turkey Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
10.3.4 UAE Immune Cell Therapy Drugs Market Size and Forecast (2020-2031)
11 Market Dynamics
11.1 Immune Cell Therapy Drugs Market Drivers
11.2 Immune Cell Therapy Drugs Market Restraints
11.3 Immune Cell Therapy Drugs Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Immune Cell Therapy Drugs Industry Chain
12.2 Immune Cell Therapy Drugs Upstream Analysis
12.3 Immune Cell Therapy Drugs Midstream Analysis
12.4 Immune Cell Therapy Drugs Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Aquila BioMedical
BPS Bioscience
Celentyx
Crown Bioscience
DiscoverX Corporation
Explicyte
Genscript Biotech Corporation
HD Biosciences
Horizon Discovery Group
ImmunXperts
Molecular Imaging
Promega Corporation,Personalis
STC Biologics
听
听
*If Applicable.
